Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Surveillance, Natural History, Quality of Care and Outcomes of Diabetes Mellitus With Onset in Childhood and Adolescence, RFA DP 10-001, Initial Review, 13560 [2010-6180]
Download as PDF
<![CDATA[
13560
Federal Register / Vol. 75, No. 54 / Monday, March 22, 2010 / Notices
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Paul Tran at
least 7 days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm111462.htm for
procedures on public conduct during
advisory committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
pertaining to announcements of meetings and
other committee management activities, for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 16, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Surveillance,
Natural History, Quality of Care and
Outcomes of Diabetes Mellitus With
Onset in Childhood and Adolescence,
RFA DP 10–001, Initial Review
[FR Doc. 2010–6169 Filed 3–19–10; 8:45 am]
BILLING CODE 4160–01–S
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Knowledge
Synthesis Center for Evaluating
Genomic Application in Practice and
Prevention, GD 10–001, Initial Review
pwalker on DSK8KYBLC1PROD with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10 a.m.–5 p.m., May 25,
2010 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Knowledge Synthesis Center for
Evaluating Genomic Application in Practice
and Prevention, GD 10–001.’’
Contact Person for More Information:
Donald Blackman, PhD, Scientific Review
Officer, National Center for Chronic Disease
Prevention and Health Promotion, Office of
the Director, Extramural Research Program
Office, 4770 Buford Highway, NE., Mailstop
K–92, Atlanta, GA 30341, Telephone: (770)
488–3023, E-mail: DBY7@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
16:41 Mar 19, 2010
Jkt 220001
[FR Doc. 2010–6194 Filed 3–19–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): RFA DD 10–002
Public Health Research on Spina
Bifida, RFA DD 10–003 Public Health
Research on Children and Adults
Living With Spina Bifida, RFA DD 10–
004 Developing a Prospective
Assessment of the Development,
Health, and Condition Progression in
Young Children With Spina Bifida,and
RFA DP 10–006 Epidemiologic Study
of Inflammatory Bowel Disease, Initial
Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10 a.m.–5 p.m., May 27,
2010 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Surveillance, Natural History,
Quality of Care and Outcomes of Diabetes
Mellitus With Onset in Childhood and
Adolescence, RFA DP 10–001.’’
For More Information Contact: Donald
Blackman, PhD, Scientific Review Officer,
National Center for Chronic Disease
Prevention and Health Promotion, Office of
the Director, Extramural Research Program
Office, 4770 Buford Highway, NE., Mailstop
K–92, Atlanta, GA 30341, Telephone: (770)
488–3023, E-mail: DBY7@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Time and Date: 9 a.m.–4 p.m., April 15,
2010 (Closed)
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘RFA DD 10–002 Public Health
Research on Spina Bifida, RFA DD 10–003
Public Health Research on Children and
Adults Living with Spina Bifida, RFA DD 10–
004 Developing a Prospective Assessment of
the Development, Health, and Condition
Progression in Young Children with Spina
Bifida, and RFA DP 10–006 Epidemiologic
Study of Inflammatory Bowel Disease.’’
Contact Person for More Information:
Donald Blackman, Ph.D., Scientific Review
Officer, National Center for Chronic Disease
Prevention and Health Promotion, Office of
the Director, Extramural Research Program
Office, 4770 Buford Highway, NE., Mailstop
K–92, Atlanta, GA 30341, Telephone: (770)
488–3023, Email: DBY7@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 12, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Dated: March 12, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–6180 Filed 3–19–10; 8:45 am]
[FR Doc. 2010–6178 Filed 3–23–10; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Nov<24>2008
Dated: March 12, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00078
Fmt 4703
Sfmt 9990
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 75, Number 54 (Monday, March 22, 2010)]
[Notices]
[Page 13560]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6180]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Surveillance, Natural History, Quality of Care
and Outcomes of Diabetes Mellitus With Onset in Childhood and
Adolescence, RFA DP 10-001, Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 10 a.m.-5 p.m., May 27, 2010 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of ``Surveillance, Natural
History, Quality of Care and Outcomes of Diabetes Mellitus With
Onset in Childhood and Adolescence, RFA DP 10-001.''
For More Information Contact: Donald Blackman, PhD, Scientific
Review Officer, National Center for Chronic Disease Prevention and
Health Promotion, Office of the Director, Extramural Research
Program Office, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, GA
30341, Telephone: (770) 488-3023, E-mail: DBY7@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 12, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-6180 Filed 3-19-10; 8:45 am]
BILLING CODE 4163-18-P
